Long-term nonprogressive infection with human immunodeficiency virus type 1 in a hemophilia cohort

Journal of Infectious Diseases

Volumn 180, Issue 6, 1999, Pages 1790-1802

  Greenough, Thomas C ^a   Brettler, Doreen B ^b   Kirchhoff, Frank ^c   Alexander, Louis ^d   Desrosiers, Ronald C ^d   O'Brien, Stephen J ^e   Somasundaran, Mohan ^a   Luzuriaga, Katherine ^a   Sullivan, John L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b University of Massachusetts   (United States)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d HARVARD MEDICAL SCHOOL   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; LYMPHOCYTE SURFACE MARKER;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; HEMOPHILIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEM CELL; T LYMPHOCYTE SUBPOPULATION; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS TITRATION;

CD4 LYMPHOCYTE COUNT; CHEMOKINES; COHORT STUDIES; HEMOPHILIA A; HIV INFECTIONS; HIV LONG-TERM SURVIVORS; HIV-1; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE ACTIVATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, CHEMOKINE; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC; VIRAL LOAD; VIRUS REPLICATION;

EID: 0032728742     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315128     Document Type: Article

References (66)

1. 1. Embretson J, Zupancic M, Ribas JL, et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993:362:359-62.
2. 2. Mellors JW, Rinaldo CR, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996;272:1167-70.
3. 3. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-22.
4. 4. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996;271:1582-6.
5. 5. CDC. Report of the NIH panel to define principles of therapy of HIV infection and Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. MMWR Morb Mortal Wkly Rep 1998;47.
6. 6. Smith MW, Dean M, Carrington M, et al. Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Science 1997;277:959-65.
7. 7. Winkler C, Modi W, Smith MW, et al. Genetic restriction of AIDS pathogcnesis by an SDF-1 chemokine gene variant. Science 1998;279:389-93.
8. 8. Saha K, Volsky DJ. Are b-chemokines innocent bystanders in HIV type 1 disease progression? AIDS Res Hum Retroviruses 1998;14:1-2.
9. 9. Richman DD, Bozette SA. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J Infect Dis 1994;169:968-74.
10. 10. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J Exp Med 1997;185:621-8.
11. 11. Connor RI, Ho DD. Human immunodeficiency virus type 1 variants with increased replicative capacity develop during the asymptomatic stage before disease progression. J Virol 1994;68:4400-8.
12. 12. Connor RI, Sheridan KE, Lai C, Zhang L, Ho DD. Characterization of the functional properties of env genes from long-term survivors of human immunodeficiency virus type 1 infection. J Virol 1996;70:5306-11.
13. 13. Somasundaran M, Robinson HL. A major mechanism of human immunodeficiency virus-induced cell killing does not involve cell fusion. J Virol 1987;61:3114-9.
14. 14. Pal A. Greenough TC, Sullivan JL, Somasundaran M. In vitro characterization of adult primary HIV-1: demonstration of distinctive single-cell killing phenotypes in spite of similar levels of viral replication. J Infect Dis 1997;176:933-40.
15. 15. Kirchhoff F, Greenough TC, Brettler DB, Sullivan JL, Desrosiers RC. Absence of intact nef sequences in a long-term, nonprogressing survivor of HIV-1 infection. N Engl J Med 1995;332:228-32.
16. 16. Deacon N, Tsykin A, Solomon A. Genomic structure of an attenuated quasispecies of HIV-1 from a cohort of a blood transfusion donor and recipients. Science 1995;270:988-91.
17. 17. Salvi R, Garbuglia AR, Di Caro A, Pulciani S, Montella F, Benedetto A. Grossly defective nef gene sequences in a human immunodeficiency vims type 1-seropositive long-term nonprogressor. J Virol 1998;72:3646-57.
18. 18. Huang Y, Zhang L, Ho DD. Characterization of nef sequences in long-term survivors of human immunodeficiency virus type 1 infection. J Virol 1995;69:93-100.
19. 19. Huang Y, Zhang L, Ho DD. Biological characterization of nef in long-term survivors of human immunodeficiency virus type 1 infection. J Virol I995;69:8142-6.
20. 20. Michael NL, Chang G, LA d A, et al. Defective accessory genes in a human immunodeficiency virus type 1-infected long-term survivor lacking recoverable virus. J Virol 1995;69:4228-36.
21. 21. Wang B, Ge YC, Palasanthiran P, et al. Gene defects clustered at the C-terminus of the vpr gene of HIV-1 long-term nonprogressing mother and child pair: In vivo evolution of vpr quasispecies in blood and plasma. Virology 1996;223:224 32.
22. 22. Mariani R, Kirchhoff F, Greenough TC, Sullivan JL, Desrosiers RC, Skowronski J. High frequency of defective nef alleles in a long-term survivor with nonprogressive human immunodeficiency virus type 1 infection. J Virol 1996;70:7752-64.
23. 23. Greenough TC, Brettler DB, Somasundaran M, Panicali DL, Sullivan JL. Human Immunodeficiency Virus type 1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo. J Infect Dis 1997;176:118-25.
24. 24. Riviere Y, McChesney MB, Porrot F, et al. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. AIDS Res Hum Retroviruses 1995;11:903-7.
25. 25. Rosenberg ES, Billingsley JM, Caliendo AM, et al. Vigorous HIV-1 specific CD4 T cell responses associated with control of viremia. Science 1997; 278:1447-50.
26. 26. Rinaldo C, Huang X-L, Fan Z, et al. High levels of anti-human immunodeficiency virus type I (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load arc associated with lack of disease in HIV-1-infected long-term nonprogressors. J Virol 1995;69:5838-42.
27. 27. Borrow P, Lewicki H, Wei X, et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 1997; 3:205-11.
28. 28. Goulder P, Phillips R, Colbert R, et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 1997;3:212-7.
29. 29. Price D, Goulder P, Klenerman P, et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci USA 1997;94:1890-5.
30. 30. Goulder P, Bunce M, Krausa P, et al. Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV lype 1 infection. AIDS Res Hum Retroviruses 1996; 12:1691-8.
31. 31. Harrer E, Harrer T, Barbosa P, et al. Recognition of the highly conserved YMDD region in the human immunodeficiency virus type 1 reverse transcriptase by HLA-A2?restricted cytotoxic T lymphocytes from an asymptomatic long-term nonprogressor. J Infect Dis 1996;173:476-9.
32. 32. Sheppard HW, Lang W, Ascher M, Vittinghoff E, Winkelstein W. The characterization of nonprogressors: long-term HIV-1 infection with stable CD4 T cell levels. AIDS 1993;7:1159-66.
33. 33. Pantaleo G, Menzo S, Vaccarezza M, et al. Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. N Engl J Med 1995;332:209-16.
34. 34. Harrer T, Harrer E, Kalams SA, et al. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. Breadth and specificity of the response and relation to in vivo viral quasispecies in a person with prolonged infection and low viral load. J Immunol 1996;156:2616-23.
35. 35. Ferbas J, Kaplan AH, Hausner M, et al. Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity. J Infect Dis 1995;172:329-39.
36. 36. Buchbinder SP, Katz MH, Hessol NA, O'Malley PM, Holmberg SD. Long-term HIV-1 infection without immunologie progression. AIDS 1994;8: 1123-8.
37. 37. Cao Y. Qin L, Zhang L, Safrit J, Ho DD. Virologie and immunologie characterization of long-term survivors of human immunodeficiency virus type 1 infection. N Engl J Med 1995;332:201-8.
38. 38. Greenough TC, Sullivan JL, Desrosiers RC. Declining CD4 T-cell counts in a person infected with nef-deleted HIV-1. N Engl J Med 1999;340:236-7.
39. 39. Greenough TC, Somasundaran M, Brettler DB, et al. Normal immune function and inability to isolate virus in culture in an individual with long-term human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 1994;10:395-403.
40. 40. Finzi D, Hermankova M, Pierson T, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997; 278:1295-300.
41. 41. Division of AIDS, National Institute of Allergy and Infectious Diseases. DAIDS virology manual for HIV laboratories. Washington, DC: US Dept. of Health and Human Services, 1997. NIH-97-3828.
42. 42. Trkola A, Ketas T, Kewalramani VN, et al. Neutralization sensitivity of human immunodeficiency virus type 1 primary isolates to antibodies and CD4-based reagents is independent of coreceptor usage. J Virol 1998; 72: 1876-85.
43. 43. Cecilia D, KewalRamani VN, O'Leary J, et al. Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage. J Virol 1998;72:6988-96.
44. 44. Rodrigo AG, Goracke PC, Rowhanian K, Mullins JI. Quantitation of target molecules from polymerase chain reaction-based limiting dilution assays, AIDS Res Hum Retroviruses 1997;13:737-42.
45. 45. Koup RA, Pikora CA, Luzuriaga K, et al. Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities. J Exp Med 1991;174:1593-600.
46. 46. Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996;2:1240-3.
47. 47. Remington RD, Schork MA, Statistics with applications to the biological sciences. Englewood Cliffs, NJ: Prentice-Hall, 1970.
48. 48. Munoz A, Kirby AJ, He YD, et al. Long-term survivors with HIV-1 infection: incubation period and longitudinal patterns of CD4+ lymphocytes. J Acquir Immune Defic Syndr Hum Retrovirol 1995;8:496-505.
49. 49. Rutherford GW, Lifson AR, Hessol NA, et al. Course of HIV-1 infection in a cohort of homosexual and bisexual men: an 11 year follow up study. BMJ 1990;301:1183-8.
50. 50. Aldhous MC, Raab GM, Doherty KV, Mok JYQ, Bird AG, Froebel KS. Age-related ranges of memory, activation, and cytotoxic markers on CD4 and CD8 cells in children. J Clin Immunol 1994;14:289-98.
51. 51. Darby SC, Ewart DW, Giangrande PLF, Spooner RJD, Rizza CR, Organisation UKHCD. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. Lancet 1996;347:1573-9.
52. 52. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996;273:1856-62.
53. 53. Zimmerman PA, Buckler-White A, Alkhatib G, et al. Inherited resistance to HIV-1 conferred by an inactivating mutation in CC chemokine receptor 5: Studies in populations with contrasting clinical phenotypes, defined racial background, and quantified risk. Mol Med 1997;3:23-36.
54. 54. Koup RA, Sullivan JL, Levine PH, et al. Detection of major histocompatibility complex class I restricted HIV-specific cytotoxic T lymphocytes in the blood of infected hemophiliacs. Blood 1989;73:1909-14.
55. 55. Carmichael A, Jin X, Sissons P, Borysiewicz L. Quantitative analysis of the human immunodeficiency virus type 1 response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J Exp Med 1993;177:249-56.
56. 56. Mills J. Effects of 13-17 years of infection with a nef-decleted strain of HIV: the Sydney Blood Bank Cohort. Onzieme Colloque des Cent Gardes 1997;293-9.
57. 57. Luzuriaga K, Koup RA, Pikora CA, Brettler DB, Sullivan JL. Deficient human immunodeficiency virus type 1-specific cytotoxic T cell responses in vertically infected children. J Pediatr 1991;119:230-6.
58. 58. Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB. Virus specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994;68:6103-10.
59. 59. Koenig S, Conley AJ, Brewah YA, et al. Transfer of HIV-1-specific cytotoxic T lymphocytes to an AIDS patient leads to selection for mutant HIV variants and subsequent disease progression. Nat Med 1995;1:330-6.
60. 60. Haas G, Plikat U, Debre P, et al. Dynamics of viral variants in HIV-1 nef and specific cytotoxic T lymphocytes in vivo. J Immunol 1996;157: 4212-21.
61. 61. Ogg GS, Jin X, Bonhoeffer S, et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998;279:2103-6.
62. 62. Musey L, Hughes J, Schacker T, Shea T, Corey L, McElrath MJ. Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Mod 1997;337:1267-74.
63. 63. Michael NL, Chang G, Louie LG, et al. The role of viral phenotype and CCR-5 gene defects in HIV-1 transmission and disease progression. Nat Med 1997;3:338-40.
64. 64. Cohen OJ, Paolucci S, Bende SM, et al. CXCR4 and CCR5 genetic polymorphisms in long-term nonprogressive human immunodeficiency virus infection: lack of association with mutations other than CCR5-D32. J Virol 1998;72:6215-7.
65. 65. Kaslow RA, Carrington M. Apple R, et al. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat Med 1996;2:405-11.
66. 66. Carrington M, Nelson GW, Martin MP, et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 1999; 283:1748-52.